Rheumatoid arthritis and ocular myasthenia gravis: Effectiveness of rituximab in the management of these two diseases

Reumatol Clin (Engl Ed). 2018 May-Jun;14(3):179-180. doi: 10.1016/j.reuma.2017.05.006. Epub 2017 Jun 16.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Drug Substitution
  • Etanercept / adverse effects
  • Etanercept / therapeutic use
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Myasthenia Gravis / chemically induced
  • Myasthenia Gravis / complications
  • Myasthenia Gravis / drug therapy*
  • Myasthenia Gravis / immunology
  • Prednisone / therapeutic use
  • Remission Induction
  • Rituximab / therapeutic use*

Substances

  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Rituximab
  • Etanercept
  • Prednisone